Interactions of Immunopathological Mediators (Tumor Necrosis Factor-α, TGF-β, Prostaglandin E2) in Traumatized Individuals

  • C. L. Miller-Graziano
  • G. Szabo
  • K. Kodys
  • B. Mehta


Characterization of monokine action in septic shock is complicated by the interactive nature of the cytokines and the unusual activation status of the posttrauma macrophage-monocytes (MØ). The response of preseptic trauma patients’ MØ to bacterial stimuli is exaggerated when compared to normals’ MØ [1, 2]. MØ from trauma patients not only produce elevated tumor necrosis factor-α (TNF-α) levels, but the TNF-α which patients’ MØ produce is primarily cell-associated rather than secreted TNF-α as produced by normals’ MØ [1, 3, 4]. The trauma patients’ MØ TNF-α is often resistant to prostaglandin E2 (PGE2) downregulation [3]. One hypothesis explaining this posttrauma aberrant monokine function is that the microenvironment around trauma patients’ MØ consists of high concentrations of secondary inducers of monokines (for example, substance P, immunoglobulin monomers, and complement split products), as well as elevated cytokines. It is the concomitant presence of these trauma-induced mediators during subsequent MØ induction that results in deranged monocyte responses, such as exaggerated production of some monokines and depression of both MØ antigen-presenting function and MØ plasmin-ogen-activator production. Some examples of altered cytokine response capacities of trauma patients’ MØ versus normals’ MØ are given in this section, and the implication for prophylactic therapy is discussed.


Trauma Patient PGE2 Level Lipoxygenase Inhibitor Muramyl Dipeptide Nordihydroguaiaretic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller-Graziano CL et al. (1990) J Trauma 30:S86PubMedCrossRefGoogle Scholar
  2. 2.
    Szabo G et al. (1991) J Clin Immunol 11:326PubMedCrossRefGoogle Scholar
  3. 3.
    Takayama T et al. (1990) Arch Surg 125:29PubMedCrossRefGoogle Scholar
  4. 4.
    Munoz C et al. (1991) Eur J Immunol 21:2177PubMedCrossRefGoogle Scholar
  5. 5.
    Miller-Graziano CL et al. (1988) Arch Surg 123:293PubMedCrossRefGoogle Scholar
  6. 6.
    Ertel W et al. (1989) Arch Surg 124:1437PubMedCrossRefGoogle Scholar
  7. 7.
    Debets JMH et al. (1988) J Immunol 141:1197PubMedGoogle Scholar
  8. 8.
    Krutmann J et al. (1990) J Immunol 145:1337PubMedGoogle Scholar
  9. 9.
    Debets JMH et al. (1990) J Immunol 144:1304PubMedGoogle Scholar
  10. 10.
    Pullicino EA et al. (1990) Lymphokine Res 9:231PubMedGoogle Scholar
  11. 11.
    Ayala A et al. (1991) Am J Physiol 210:R167Google Scholar
  12. 12.
    Patek PQ et al. (1989) Immunol 67:509Google Scholar
  13. 13.
    Liu C-C et al. (1989) Proc Natl Acad Sci USA 86:3286PubMedCrossRefGoogle Scholar
  14. 14.
    Kunkel SL et al. (1988) Methods Achiev Exp Pathol 13:240PubMedGoogle Scholar
  15. 15.
    Renz H et al. (1988) J Immunol 141:2388PubMedGoogle Scholar
  16. 16.
    Pace JL et al. (1984) Mol Immunol 21:249PubMedCrossRefGoogle Scholar
  17. 17.
    Goodwin J et al. (1988) In: Biology of the leukotrienes. NY Acad Sci, p 201Google Scholar
  18. 18.
    Schade U et al. (1989) Lymphokine Res 8:245PubMedGoogle Scholar
  19. 19.
    Lee J et al. (1989) Agents Actions 27:277PubMedCrossRefGoogle Scholar
  20. 20.
    Rola-Pleszczynski M et al. (1988) In: Biology of the Leukotrienes NY Acad Sci, p 218Google Scholar
  21. 21.
    Szabo G et al. (1990) J Leukoc Biol 47:206PubMedGoogle Scholar
  22. 22.
    Palladino MA et al. (1990) Transforming growth factor-βs. Ann NY Acad Sci 593:181PubMedCrossRefGoogle Scholar
  23. 23.
    Wahl SM et al. (1990) Transforming growth factors-βs Ann Acad Sci 593:188CrossRefGoogle Scholar
  24. 24.
    Miller-Grazino CL et al. (1991) J Clin Immunol 11:95CrossRefGoogle Scholar
  25. 25.
    Kehrl JH et al. (1991) J Immunol 146:4016PubMedGoogle Scholar
  26. 26.
    Wong HL et al. (1991) J Immunol 147:1843PubMedGoogle Scholar
  27. 27.
    Twardzik DR et al. (1990) Transforming growth factors-βs. Ann NY Acad Sci 593:276PubMedCrossRefGoogle Scholar
  28. 28.
    Szabo G et al. (1991) J Clin Immunol 11:336PubMedCrossRefGoogle Scholar
  29. 29.
    Paul WE et al. (1987) Annu Rev Immunol 5:429PubMedCrossRefGoogle Scholar
  30. 30.
    Zlotkik A et al. (1987) J Immunol 138:4275Google Scholar
  31. 31.
    Essner R et al. (1989) J Immunol 142:3857PubMedGoogle Scholar
  32. 32.
    Donnelly RP et al. (1990) J Immunol 145:569PubMedGoogle Scholar
  33. 33.
    Hart PH et al. (1989) Proc Natl Acad Sci USA 86:3803PubMedCrossRefGoogle Scholar
  34. 34.
    Lee JD et al. (1990) J Leukoc Biol 47:475PubMedGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1993

Authors and Affiliations

  • C. L. Miller-Graziano
    • 1
  • G. Szabo
    • 1
  • K. Kodys
    • 1
  • B. Mehta
    • 1
  1. 1.Department of SurgeryUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations